Drug Profile
Cervical cancer vaccine - Immunitor
Alternative Names: V3-cervixLatest Information Update: 19 Mar 2021
Price :
$50
*
At a glance
- Originator Immunitor
- Class Anti-inflammatories; Cancer vaccines; Immunotherapies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Cervical cancer
Most Recent Events
- 19 Mar 2021 Phase II trial is still ongoing for Cervical cancer in Mongolia (PO) (NCT03550755)
- 01 Jul 2018 Phase-II clinical trials in Cervical cancer in Mongolia (PO) before June 2018 (NCT03550755)